Vyant Bio, Inc.
VYNT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $666 | $1,148 | $867 | $7,305 |
| % Growth | -42% | 32.4% | -88.1% | – |
| Cost of Goods Sold | $1,008 | $1,847 | $1,101 | $3,701 |
| Gross Profit | -$342 | -$699 | -$234 | $3,604 |
| % Margin | -51.4% | -60.9% | -27% | 49.3% |
| R&D Expenses | $6,772 | $4,273 | $3,232 | $0 |
| G&A Expenses | $0 | $0 | $0 | $5,171 |
| SG&A Expenses | $8,798 | $8,424 | $2,717 | $6,317 |
| Sales & Mktg Exp. | $8,798 | $8,424 | $2,717 | $1,146 |
| Other Operating Expenses | $0 | $57 | $11 | $0 |
| Operating Expenses | $15,570 | $12,697 | $5,949 | $6,317 |
| Operating Income | -$15,912 | -$15,706 | -$7,623 | -$2,713 |
| % Margin | -2,389.2% | -1,368.1% | -879.2% | -37.1% |
| Other Income/Exp. Net | $105 | -$2,869 | -$1,027 | -$4,507 |
| Pre-Tax Income | -$15,807 | -$18,575 | -$8,650 | -$7,220 |
| Tax Expense | $6,883 | $27,520 | $546 | -$512 |
| Net Income | -$22,690 | -$46,095 | -$9,196 | -$6,708 |
| % Margin | -3,406.9% | -4,015.2% | -1,060.7% | -91.8% |
| EPS | -3.87 | -10.19 | -18.5 | -17.4 |
| % Growth | 62% | 44.9% | -6.3% | – |
| EPS Diluted | -3.87 | -10.19 | -18.5 | -17.4 |
| Weighted Avg Shares Out | 5,868 | 4,525 | 497 | 386 |
| Weighted Avg Shares Out Dil | 5,868 | 4,525 | 497 | 386 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $108 |
| Interest Expense | $93 | $0 | $535 | $1,437 |
| Depreciation & Amortization | $843 | $8,228 | $2,561 | $757 |
| EBITDA | -$14,871 | -$15,706 | -$5,062 | -$2,213 |
| % Margin | -2,232.9% | -1,368.1% | -583.9% | -30.3% |